Insider Transactions in Q1 2022 at Chemo Centryx, Inc. (CCXI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2022
|
Rita Jain EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+15.73%
|
-
|
|
Jan 21
2022
|
Joseph M Feczko Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+11.67%
|
$562,500
$15.16 P/Share
|
|
Jan 01
2022
|
Markus J. Cappel Chief Bus. Officer & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,538
-10.81%
|
$415,368
$36.41 P/Share
|
|
Jan 01
2022
|
Markus J. Cappel Chief Bus. Officer & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,934
+6.55%
|
-
|
|
Jan 01
2022
|
Susan M Kanaya Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
16,847
-11.26%
|
$606,492
$36.41 P/Share
|
|
Jan 01
2022
|
Susan M Kanaya Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
30,799
+6.89%
|
-
|
|
Jan 01
2022
|
Thomas J. Schall President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,698
-1.87%
|
$1,645,128
$36.41 P/Share
|
|
Jan 01
2022
|
Thomas J. Schall President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
84,234
+1.15%
|
-
|